ARCHIVES

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 2 | February 25, 2005

Download PDF Visit The Full Archive

Related Articles

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

November 28, 2008

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Masons Give $65 Million to Univ. of Minnesota Cancer Center.

April 25, 2008

Centers Subcommittee Suggests Construction Grant Guidelines; New Constructions Regulations Proposed

March 28, 1975

In Brief: ASCO Letter To Clinton Urges support For Trials; Senator Praises NCI, Bristol; Berlin Back A NCI

January 15, 1993